ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 175630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 175630; 2) Community: the network communities that were significantly associated with the response to NSC 175630; 3) Molecule: the relationships between components within communities and NSC 175630; 4) MDR: the compounds that were significantly associated with the NSC 175630.

NSC Compound Enrichment Correlation
NSC 665087 Null 0.0286383688883668 0.52186137
NSC 667740 Null 0.0286383688883668 -0.21072093
NSC 682769 5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- 0.0286383688883668 0.061558526
NSC 690972 Null 0.0286383688883668 0.2747143
NSC 692576 3-Pyridinecarboxylic acid, 2-[[(2-chloro-3-pyridinyl)amino]carbonyl]-1,4-dihydro- 4-(2,4-dimethoxyphenyl)-1-(4-methoxy-2-nitrophenyl)- 6-(4-methylphenyl)-, methyl ester 0.0286383688883668 0.42294143
NSC 693858 Null 0.0286383688883668 0.37311744
NSC 699071 Null 0.0286383688883668 0.17819492
NSC 701574 Androst-4-en-3-one, 17-ethynyl-17-hydroxy-, 3-O-[2-(1-pyrrolidinyl)ethyl]oxime, (17.beta.)- 0.0286383688883668 0.20396343
NSC 708049 Piperazine-2,2,5,5-tetracarbonitrile, 3,6-dipropyl- 0.0286383688883668 0.55281176
NSC 709435 Null 0.0286383688883668 0.18887147
Total:58  Current:33    [First] [Prev] [Next] [Last]